Determinants of Osteopenia in Male Renal-Stone Disease Patients with Idiopathic Hypercalciuria
|
|
- Bonnie Simon
- 5 years ago
- Views:
Transcription
1 Article Determinants of Osteopenia in Male Renal-Stone Disease Patients with Idiopathic Hypercalciuria Emmanuel Letavernier,* Olivier Traxer, Michel Daudon, Mohammed Tligui, Jérôme Hubert-Brierre, Dominique Guerrot,* Aline Sebag, Laurent Baud,* and Jean-Philippe Haymann* Summary Background and objectives Bone demineralization is frequent in renal-stone formers with hypercalciuria. Although this pathologic link has been recognized for decades, the underlying mechanisms and risk factors associated with osteopenia/osteoporosis in this population remain partially understood. Design, setting, participants, & measurements This study retrospectively analyzed determinants of low bone mineral density (BMD) in 65 idiopathic hypercalciuric male renal-stone formers. Clinical and biologic evaluation included BMD measurement, bone-remodeling markers, analysis of calcium metabolism with oral calcium load test, and dietary inquiry. Results Patients with osteopenia (n 23, 35% of the population) presented significantly higher fasting calciuria as compared with normal bone density patients (n 42) (calcium/creatinine ratio was 0.32 versus 0.24 mmol/mmol; P 0.006). Analysis of the whole population revealed a negative association between fasting hypercalciuria and BMD (P 0.003), independent of confounding variables including body-mass index and tobacco consumption. The fasting calcium/creatinine ratio above 0.25 mmol/mmol was associated with a 3.8-fold increase in the risk of low BMD. Conclusion In our study, fasting hypercalciuria after a 2-day calcium-restricted diet appears as the only biologic factor associated with low BMD, suggesting a bone-calcium efflux. Our results support the view of a parathyroid-independent pathologic process that remains to be identified. Hypercalciuric patients with low BMD do not excrete more calcium in 24-hour urine samples than patients without low BMD. Clin J Am Soc Nephrol 6: , doi: /CJN Introduction The association between urolithiasis and fractures was reported more than 30 years ago (1). In a North- American cohort study, Melton et al. (2) identified that the vertebral-fracture incidence rate was increased almost four-fold in lithiasic patients in comparison with the general population, independently from age or steroid intake. Interestingly, the relative risk of fracture was higher for men than women. In another cross-sectional study, Lauderdale et al. (3) reported that men, but not women, with a history of kidney stones presented significantly more wrist and spine fractures. Thus, the early recognition of patients at risk for osteopenia, before the occurrence of pathologic bone fractures, would be of clinical value. Indeed, because fractures occur after decades, most of observational and epidemiologic works are based upon bone mineral density (BMD) as a surrogate marker in renal-stone formers (4,5). However, BMD measurement in renal-stone formers is expensive and is currently not performed in routine practice, because urolithiasis affects more than 10% of the population in France and most Western countries (6,7). According to previous studies, hypercalciuria has been reported to be the major risk factor both for urolithiasis and bone-mass loss, thus raising the issue of whether a calcium homeostasis imbalance occurs not only in patients with a diagnosis of primary hyperparathyroidism but also in most patients with idiopathic hypercalciuria (5). The aim of this work was to study retrospectively the prevalence of osteopenia and to identify the biologic factors associated with a low BMD in a series of 65 idiopathic hypercalciuric renal-stone disease male patients. Materials and Methods Study Population Eighty-five male renal-stone formers with hypercalciuria were referred to our center for a routine medical evaluation including a BMD test of the spine, femoral neck, and forearm (assessed by dualenergy x-ray absorptiometry), a 24-hour urine collection under a normal diet, and an oral calcium load performed 48 hours after a calcium-restricted diet. To be included in the study, subjects had to *INSERM, UMR S 702, F-75020, Paris, France; Université Pierre et Marie Curie, Paris 06, UMR S 702, F-75020, Paris, France; Assistance publique- Hôpitaux de Paris, Hôpital Tenon, F , Paris, France; Assistance publique- Hôpitaux de Paris, Hôpital Necker, F , Paris, France; and Assistance publique-hôpitaux de Paris, Hôpital Rothschild, F-75012, Paris, France Correspondence: Dr. Emmanuel Letavernier, Service des Explorations Fonctionnelles Multidisciplinaires, Hôpital Tenon, 4 Rue de la Chine, Paris, France. Phone: ; Fax: ; emmanuel.letavernier@ tnn.aphp.fr Vol 6 May, 2011 Copyright 2011 by the American Society of Nephrology 1149
2 1150 Clinical Journal of the American Society of Nephrology have a past medical history of hypercalciuria defined by a 24-hour urine calcium excretion greater than 0.1 mmol/kg of body weight. Exclusion criteria included primary hyperparathyroidism (n 6); renal tubular acidosis (n 1); ongoing diuretic therapy (including acetazolamide and hydrochlorothiazide) (n 3); vitamin D, calcium supplementation, or bisphosphonate intake within 6 months (n 4); renal failure (assessed by a measured creatinine clearance lower than 60 ml/min per 1.73 m 2 )(n 2); enteric or primary hyperoxaluria (n 1); and incomplete 24-hour urine samples (n 3). In the end, 65 male patients were included in our study. Concise Methods All of the urine collections and oral calcium load were performed at least 3 months after lithotripsy or surgery. A 24-hour urine collection under a regular diet was performed at baseline to measure the following parameters: diuresis volume, calcium, magnesium, phosphate, sodium, potassium, creatinine, urea, oxalate, uric acid, citrate, ammonium, and deoxypyridinoline excretion. Then, after a 2-day calcium-free diet including low-calcium drinking water (Volvic ), patients were referred to our unit for an oral calcium load. Briefly, a fasting blood sample was analyzed for total and ionized calcium, phosphate, magnesium, creatinine, uric acid, bicarbonates, parathyroid hormone (PTH), 25(OH)-D3, and 1,25(OH)-D3 vitamins. Bone remodeling biomarkers (serum bone alkaline phosphatase and osteocalcin) were also performed at that time. A fasting urine sample over a 30-minute period was also collected to measure calcium, creatinine, and phosphate. Phosphate tubular reabsorption rate and creatinine clearance were measured, and TmPO4/GFR was calculated according to the method of Bijvoet and Morgan (8). An oral calcium load (calcium carbonate 1g PO) was given, and 90 minutes later another 2-hour urinary collection was performed (analyzed for calcium, creatinine, and phosphate) with simultaneous blood sample analysis for total and ionized calcium, phosphate, creatinine, and PTH (9). All of the patients were subjected to a dietary inquiry to evaluate intakes over 1 week on usual diet, including calcium intake. Assays Serum and urinary creatinine levels were measured by the Jaffe method on a Konelab 20 analyzer from Thermo Fisher Scientific. Uric acid levels were measured with the Konelab analyzer. Total CO 2 in blood, ionized calcium, sodium, and potassium levels were measured with an ABL 815 from Radiometer. Calcium and magnesium serum and urinary levels were measured with the PerkinElmer 3300 atomic absorption spectrometer. 25(OH)-D3 and 1,25(OH)-D3 were measured by radioimmunoassays kits from Immunodiagnostics Systems Ltd. Parathyroid hormone was measured by the ELSA-PTH kit from Cisbio International. Urinary NH4 was measured with the RANDOX Laboratories kit. The citric acid EnzyPlus kit was purchased from Biocontrol, and the oxalate assay kit was purchased from Trinity Biotech. Urinary deoxypyridoline was measured by the RIA method from Immunodiagnostics Systems Ltd. Osteocalcin serum level was assessed by the ELSA-OST-NAT kit from CisBio international. Bone alkaline phosphatase level was measured with the Ostase bone alkaline phosphatase (BAP) Enzymeimmunoassay from Immunodiagnostics Systems Ltd. Bone mineral density was measured on three sites (lumbar, radius, and femoral neck) by dual-energy x-ray absorptiometry in the radiology unit of the Rothschild Hospital (Paris, France). Statistical Analyses Quantitative values are reported as means SD. Differences between patients with and without lumbar osteopenia (i.e. L2 L4 T score 1SDor 1 SD) were assessed using the unpaired t test or the Mann-Whitney test as appropriate. The 2 test was used to compare qualitative variables. Simple and multiple linear regression analyses were used to investigate the association between L2 L4 lumbar T score and clinical/biologic factors. A stepwise logistic regression analysis was applied to estimate odds ratios and 95% confidence interval for each factor according to the presence of a low BMD (assessed by L2 L4 lumbar T score). Factors that were tested in the logistic regression were selected if the P value was less than 0.2 in the univariate phase. Moreover, body-mass index (BMI) and tobacco consumption, two clinical parameters previously reported as significant predictors of bone-mass loss, were also tested in the analysis. Sensitivity and specificity of fasting calcium/creatinine urine ratio (Ca/Cr) were calculated using lumbar osteopenia (assessed by BMD T score) as the evaluated criteria. A p value of less than 0.05 was considered significant. Statistics were performed using Statview 5.0 and Xlstat 2010 software. Results Sixty-five adult men fulfilled the inclusion criteria. Patients with renal stones and hypercalciuria were divided into two groups according to the L2 L4 lumbar T score: low BMD (T score 1 SD) or normal (T score 1 SD). All but two patients were Caucasian. Twenty-three patients (35% of the population) had a low BMD and among them, five had osteoporosis (lumbar T score 2.5 SD). As shown in Table 1, the low lumbar BMD group was also low for femoral and radial BMD, ruling out potential bias. Fifty-six patients out of 65 (86%) had an increased digestive absorption of calcium assessed by a Ca/Cr above 0.6 mmol/mmol. The comparison of clinical and biologic parameters between normal lumbar BMD and low BMD groups in our population is shown in Tables 2 and 3. Age and renalstone disease duration were similar in both groups with no significant difference in anthropometric variables, cardiovascular risk factors, or steroid intake. The number of recurrent stone formers and their disease activity were similar in the two groups. We analyzed by infrared spectroscopy 50 calcium stones from 38 patients (12 patients with osteopenia and 26 with normal BMD), but we did not identify significant differences in renal stone components between the two groups. Of interest, the dietary calcium intake, parathyroid hormone levels, or vitamin D 3 metabolites and bone-remodeling markers including BAP, osteo-
3 Clin J Am Soc Nephrol 6: , May, 2011 Determinants of Osteopenia in Male Renal-Stone Disease Patients, Letavernier et al Table 1. Bone mineral density Parameter Lumbar T Score 1 (n 42) Lumbar T Score 1 (n 23) P L2 L4 lumbar T score Femoral T score UD radius T score Bone mineral density of spine, femoral neck and forearm assessed by dual-energy X ray absorptiometry in patients with or without lumbar osteopenia. Data expressed as mean SD. UD, Ultradistal. Table 2. Clinical variables Parameter Lumbar T Score 1 (n 42) Lumbar T Score 1 (n 23) P Age, years Age at first stone, years Disease duration, years Recurrent disease, n (%) 25 (59) 12 (52) 0.76 Disease activity, n/yr Weight, kg Height, cm BMI, kg/m Hypertension, n (%) 5 (12) 5 (22) 0.49 Diabetes, n (%) 2 (5) 2 (9) 0.93 Smoking pack years Smoking, n (%) 21 (50) 12 (52) 0.93 Steroids, n (%) 4 (9) 1 (4) 0.79 Spontaneous fracture, n (%) 1 (2) 1 (4) 0.75 Calcium intake, mg/d Clinical parameters in patients with or without lumbar osteopenia. Disease activity corresponds to the number of symptomatic stone episodes/years in recurrent stone formers. Data expressed as mean SD. BMI, Body mass index. calcin, and urinary deoxypyridinoline were similar in the two groups. Whereas no significant difference was detected in the blood analyses, including ionized calcium, renal function (plasma creatinine and creatinine clearance), or acid-base status, the data analyzed from urine collections revealed that fasting calcium/creatinine excretion was significantly higher in osteopenic patients ( versus ; P 0.006). Calcium/creatinine ratio after oral calcium intake was also significantly different between the two groups, whereas no significant difference was evident for absorptive hypercalciuria ( Ca/Cr). It is noteworthy that conventional risk factors for urolithiasis were similar between the two groups, including daily urinary calcium excretion (or expressed as daily calcium/creatinine ratio), oxalate, urate, or citrate performed during unrestricted diet. Linear regression analysis provided evidence that the L2 L4 lumbar T score was negatively associated with fasting calcium/creatinine ratio and tobacco consumption (pack years) and positively associated with BMI. Moreover, fasting calcium/creatinine ratio explained 11% of variance and remained significant after adjustment for potential confounders (Table 4). Furthermore, using a multiple logistic regression analysis, a fasting calcium/creatinine ratio above 0.25 mmol/ mmol was the only parameter significantly associated with osteopenia (odds ratio 3.8; confidence interval, 1.24 to 11.5; P 0.019). The sensitivity and specificity values for detecting low BMD according to fasting calcium/creatinine are shown in Figure 1. Discussion Hypercalciuria is a major risk factor for urolithiasis (10,11). Although hypercalciuria and bone-mass loss are classic features of primary hyperparathyroidism, there is also evidence that the prevalence of osteopenia is statistically increased in lithiasic patients with idiopathic hypercalciuria in comparison with normocalciuric patients (12,13). The pathogenic classification for hypercalciuric patients proposed by Pak et al. (9) is based upon calcium urinary excretion after a calcium-free diet and after a calcium load, respectively. Briefly, patients can be divided into two groups, with absorptive hypercalciuria or fasting hypercalciuria, respectively. The mean bone mineral density is decreased in both groups, but it has been reported that the bone mineralization deficit is greater in the group of patients with fasting hypercalciuria, a conceivable situation because urinary calcium excretion necessarily originates from bone after a low-calcium diet (4,14). The fact that absorptive hypercalciuria is also associated with bone loss is less intuitive and underscores a primitive defect in bone
4 1152 Clinical Journal of the American Society of Nephrology Table 3. Biological parameters Parameter Lumbar T Score 1 (n 42) Lumbar T Score 1 (n 23) P Blood creatinine, mol/l (mg/dl) ( ) ( ) 0.94 creatinine clearance, ml/min calcium, mmol/l (mg/dl) (9 0.4) ( ) 0.32 calcium ionized, mmol/l (mg/dl) ( ) ( ) 0.77 phosphate, mmol/l (mg/dl) ( ) ( ) 0.58 TmPO4/GFR, mmol/l.gf magnesium, mmol/l (mg/dl) ( ) ( ) 0.56 total CO 2, mmol/l uric acid, mol/l (mg/dl) ( ) ( ) 0.15 osteocalcin, ng/ml (n 19.5) BAP, ng/ml (n 25) PTH, pg/ml (n 8 76) (OH)-D3, ng/ml (n 7 30) ,25(OH)-D3, pg/ml (n 17 67) Urine volume, ml/d calcium, mmol/d calcium/creatinine, mmol/mmol Calcium load test fasting Ca/Cr, mmol/mmol Cr post-load Ca/Cr, mmol/mmol Cr Ca: post-load fasting Ca/Cr ph ammonia, mmol/d oxalate, mmol/d citrate, mmol/d urea, mmol/d creatinine, mol/d phosphate, mmol/d uric acid, mol/d magnesium, mmol/d sodium, mmol/d deoxypyridinoline/cr, nmol/mmol (n 5.4) Biological parameters in patients with or without lumbar osteopenia. All biological variables were collected during usual patients diet with the exception of oral calcium load test results. Oral calcium load test results: Fasting and post-load Ca/Cr correspond to urinary calcium/creatinine ratio after a calcium-free diet and after oral calcium load respectively. is the difference between these two values (indicator of calcium digestive absorption capacities). Data expressed as mean SD. Cr, creatinine; TmPO4/GFR, ratio of maximal rate of renal tubular reabsorption of phosphate to glomerular filtration rate; GF, glomerular filtrate; Ca, calcium; BAP, Bone alkaline phosphatases; PTH, parathyroid hormone; 25(OH)-D3, 25 hydroxy-vitamin D3; 1 25(OH)-D3, 1,25 hydroxy-vitamin D3. Table 4. Linear regression model for lumbar BMD (L2 L4 T score) P R 2 R 2 change Lumbar BMD 0.23 Fasting Ca/Cr BMI, kg/m Smoking, pack years Variables independently related to lumbar spine demineralization according to a multiple regression analysis model. Data are standardized regression coefficient (beta) for the association of lumbar T-score and Fasting Ca/Cr, BMI, and Smoking. Data expressed as mean SD. BMD, Bone mineral density; BMI, Body mass index; Ca/Cr, calcium/creatinine urinary ratio after calcium-free diet. mineralization: the increased absorption maintains the balance between bone calcium flux entrance and release but at the expense of hypercalciuria. This hypothesis is supported by studies showing that a low-calcium diet results in an excessively negative calcium balance in patients with idiopathic hypercalciuria and renal stones (15). This finding
5 Clin J Am Soc Nephrol 6: , May, 2011 Determinants of Osteopenia in Male Renal-Stone Disease Patients, Letavernier et al Figure 1. Sensitivity and specificity curves for lumbar spine demineralization (T score < 1) according to the different values of fasting calcium/creatinine ratio in urine samples after a calcium-free diet. justifies that restriction of calcium in the diet has been abandoned for years. Finally, Vezzoli et al. (16) have shown that hypercalciuric stone-forming women with high intestinal calcium absorption are particularly at risk of bone-mass loss, providing evidence for the implication of bone tissue involvement in idiopathic hypercalciuria. To avoid interferences caused by hormonal status and/or hormonal therapy and because increased fracture prevalence and bone demineralization was reported in men, we focused our study on idiopathic hypercalciuric male renal-stone formers (2). Age was similar in patients with or without bone-mass loss. This negative finding highlights that the determinants of osteopenia in renal-stone formers differ from the general population. The fact that these patients are relatively young emphasizes the importance of adequate predictive tools allowing early medical care in this population. Literature is conflicting about the efficiency of biologic markers of bone remodeling in renal-stone formers (5). Here, we studied osteocalcin, bone alkaline phosphatase, and urinary deoxypyridinoline, two markers of bone anabolism and one involved in bone catabolism, respectively. We failed to identify any of them as a useful diagnosis marker in our population. However, these results do not preclude their potential use in postmenopausal women. They may also be relevant in the follow-up or to better characterize the pathologic mechanism at play: high versus low bone extracellular matrix remodeling. This point may be critical if a bisphosphonate therapy is discussed. By contrast, we observed that BMI was inversely correlated to bone-mass loss, a classical finding (17). The classical relationship between smoking (number of pack years) and osteopenia was also identified (Table 4). Fasting hypercalciuria after a 2-day calcium restricted diet could be used in the screening of bone-mass loss in male renal-stone formers. The sensitivity and specificity curves show that a calcium/creatinine ratio of 0.25 mmol/ mmol may be an interesting cut-off, a ratio above this limit increasing by 3.8-fold the risk for osteopenia (Figure 1). Interestingly, a calcium/creatinine threshold of 0.31 mmol/ mmol (0.11 mg/mg) was proposed by Pak et al. (9) to define fasting hypercalciuria (with no BMD evaluation). Fasting calciuria probably results from a bone loss in the absence of calcium intake, but whether fasting hypercalciuria is due to a renal leak or to a primary bone resorption is unclear. On the one hand, fasting hypercalciuria could be the consequence of a renal leak, leading to a secondary hyperparathyroidism, increased calcitriol synthesis, and therefore bone resorption (18,19). Pasch et al. (20) have recently shown that among stone formers, the patients with the lower bone mineral density have a blunted response of PTH release and an increased production of calcitriol in response to low-calcium diet. On the other hand, bone demineralization occurs in lithiasic patients despite enhanced calcium absorption, suggesting a primitive defect at the level of the skeleton. Heller et al. (21) have shown recently that although in lithiasic patients calciuria originates mainly from intestinal hyperabsorption, there was a reduced bone formation associated with a relatively increased bone resorption contributing to the hypercalciuria in this population. In addition, Gomes et al. (22) have shown that increased bone resorption in patients with idiopathic hypercalciuria is associated with a higher expression of receptor activator of nuclear factor B ligand in bone tissue. Our study rather supports their results because we observed no differences in PTH or calcitriol levels between osteopenic and nonosteopenic patients. In other
6 1154 Clinical Journal of the American Society of Nephrology words, a renal calcium leak leading to increased PTH and therefore increased calcitriol levels does not seem a straightforward mechanism in our series. Coe et al. (23) found relatively low PTH levels after a calcium-free diet in patients with idiopathic hypercalciuria. However, these two hypotheses might not be mutually exclusive. Interestingly, under a free diet, patients with low bone density had no significant increased 24-hour calciuria compared with patients with normal bone density (8.66 versus 7.74 mmol/d, respectively; P 0.39), despite a trend for intestinal calcium absorption during calcium load test performed under a normalized regimen (0.99 versus 0.80 mmol/mmol; P 0.07). The variations of calcium, sodium, and protein intake between patients probably account for the offsetting of a significant difference. It is noteworthy that a similar finding was also reported by Tasca et al. (14) and Vezzoli et al. (12) in men under 65 years old. Previous studies reporting that 24-hour urine excretion was associated with bone-mass loss included female patients, suggesting that our results should not be extended to this population (15,24). Conclusions In male renal-stone disease patients with idiopathic hypercalciuria, fasting calcium/creatinine ratio after a brief calcium-restricted diet (but not usual bone remodeling biomarkers or 24-hour calciuria) was the only biologic significant predictor for a low BMD and as such could be a useful tool. Moreover, it suggests that osteopenia, which was present in 35% of patients, is associated with a PTH-independent demineralizing process that deserves further investigation. Disclosures None. References 1. Alhava EM, Juuti M, Karjalainen P: Bone mineral density in patients with urolithiasis: A preliminary report. Scand J Urol Nephrol 10: , Melton LJ, 3rd, Crowson CS, Khosla S, Wilson DM, O Fallon WM: Fracture risk among patients with urolithiasis: A population-based cohort study. Kidney Int 53: , Lauderdale DS, Thisted RA, Wen M, Favus MJ: Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16: , Bataille P, Achard JM, Fournier A, Boudailliez B, Westeel PF, el Esper N, Bergot C, Jans I, Lalau JD, Petit J: Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39: , Zerwekh JE: Bone disease and idiopathic hypercalciuria. Semin Nephrol 28: , Daudon M: [Epidemiology of nephrolithiasis in France]. Ann Urol 39: , Zilberman DE, Yong D, Albala DM: The impact of societal changes on patterns of urolithiasis. Curr Opin Urol 20: , Bijvoet OL, Morgan DB: Plasma-phosphate and tubular reabsorption of phosphate. Lancet 760: , Pak CY, Kaplan R, Bone H, Townsend J, Waters O: A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292: , Anderson CK, Hodgkinson A, Pyrah LN: Renal calcification, calculus formation, and the urinary excretion of calcium. Lancet 2: , Taylor EN, Curhan GC: Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol 4: , Vezzoli G, Soldati L, Arcidiacono T, Terranegra A, Biasion R, Russo CR, Lauretani F, Bandinelli S, Bartali B, Cherubini A, Cusi D, Ferrucci L: Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHI- ANTI study. Kidney Int 67: , Heilberg IP, Weisinger JR: Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15: , Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visona E, Bernardi C, Nobile M, Giannini S: Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 59: , Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, Coe FL: Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63: , Vezzoli G, Rubinacci A, Bianchin C, Arcidiacono T, Giambona S, Mignogna G, Fochesato E, Terranegra A, Cusi D, Soldati L: Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 42: , Reid IR: Relationships between fat and bone. Osteoporos Int 19: , Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE: Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311: 73 80, Krieger NS, Stathopoulos VM, Bushinsky DA: Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol 271: C130 C135, Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O: PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant 23: , Heller HJ, Zerwekh JE, Gottschalk FA, Pak CY: Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int 71: , Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP: RANKL is a mediator of bone resorption in idiopathic hypercalciuria. Clin J Am Soc Nephrol 3: , Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM: Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria andin normal subjects. Am J Med 72: 25 32, Asplin JR, Donahue S, Kinder J, Coe FL: Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int 70: , 2006 Received: November 17, 2010 Accepted: December 21, 2010 Published online ahead of print. Publication date available at
Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationBisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug
Therapeutic Advances in Musculoskeletal Disease Review Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug Ther Adv Musculoskel Dis
More informationCalcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management
REVIEW C URRENT OPINION Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management Miguel A. Arrabal-Polo a, María del Carmen Cano-García a, Benjamin K. Canales
More informationStudy of secondary causes of male osteoporosis
Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos
More informationPersistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019
Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal
More informationMedical Approach to Nephrolithiasis. Seth Goldberg, MD September 15, 2017 ACP Meeting
Medical Approach to Nephrolithiasis Seth Goldberg, MD September 15, 2017 ACP Meeting DISCLOSURES Seth Goldberg, MD Assistant Professor of Medicine Research support Abbott Kadmon Otsuka Pfizer Introduction
More informationMEDICAL STONE MANAGEMENT MADE EASY PRACTICAL ADVICE
MEDICAL STONE MANAGEMENT MADE EASY PRACTICAL ADVICE Comprehensive Kidney Stone Center at Duke University Medical Center Durham, North Carolina Glenn M. Preminger, M.D. UCLA State-of-the Art Urology 02
More informationIdiopathic hypercalciuria: Can we prevent stones and protect bones?
REVIEW LEARNING OBJECTIVE: Readers will evaluate hypercalciuria in the context of bone health LAURA E. RYAN, MD Clinical Associate Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism,
More informationIndex. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition
A Acid base balance dietary protein detrimental effects of, 19 Acid base balance bicarbonate effects, 176 in bone human studies, 174 mechanisms, 173 174 in muscle aging, 174 175 alkali supplementation
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism
Southern Derbyshire Shared Care Pathology Guidelines Primary Hyperparathyroidism Please use this Guideline in Conjunction with the Hypercalcaemia Guideline Definition Driven by hyperfunction of one or
More informationHypercalcemia. Hypercalcemia: When to Worry, When to Treat! Mineral Metabolism : A Short Course
Hypercalcemia: When to Worry, When to Treat! Michael A. Levine has no financial relationships to disclose or Conflicts of Interest to resolve. Michael A. Levine, M.D. This presentation will not involve
More informationHypercalciuria is a common and important finding in postmenopausal women with osteoporosis
European Journal of Endocrinology (2003) 149 209 213 ISSN 0804-4643 CLINCAL STUDY Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis Sandro Giannini 1,2, Martino
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationRISK FACTORS AND TREATMENT STRATEGIES FOR URINARY STONES Review of NASA s Evidence Reports on Human Health Risks
Mayo Clinic O Brien Urology Research Center RISK FACTORS AND TREATMENT STRATEGIES FOR URINARY STONES 2017 Review of NASA s Evidence Reports on Human Health Risks John C Lieske, MD July 27, 2017 What types
More informationDiet and fluid prescription in stone disease
http://www.kidney-international.org & 2006 International Society of Nephrology mini review Diet and fluid prescription in stone disease EN Taylor 1 and GC Curhan 1,2 1 Renal Division, Department of Medicine,
More informationSchool of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PLB SEMINAR
1 School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PLB SEMINAR URINARY (RENAL) STONE FORMATION An Overview What are Urinary (Renal)
More informationEvaluation of the Recurrent Stone Former
Urol Clin N Am 34 (2007) 315 322 Evaluation of the Recurrent Stone Former Paramjit S. Chandhoke, MD, PhD* Department of Urology, Northwest Permanente, Portland, OR, USA At one time, metabolic kidney stone
More informationThe Role of the Laboratory in Metabolic Bone Disease
The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology
More informationThe Parathyroid Glands
The Parathyroid Glands Bởi: OpenStaxCollege The parathyroid glands are tiny, round structures usually found embedded in the posterior surface of the thyroid gland ([link]). A thick connective tissue capsule
More informationImportant aspects of acid-base disorders
Important aspects of acid-base disorders I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Division of Nephrology, Hypertension and Transplantation University of Florida College
More information24-h uric acid excretion and the risk of kidney stones
http://www.kidney-international.org & 2008 International Society of Nephrology original article 24-h uric acid excretion and the risk of kidney stones GC Curhan 1,2,3 and EN Taylor 1,2 1 Department of
More informationBone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases
Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral
More informationEffect of calcium intake on urinary oxalate excretion in calcium stone-forming patients
Brazilian Journal of Medical and Biological Research (2002) 35: 669-675 Calcium intake and oxalate excretion ISSN 0100-879X 669 Effect of calcium intake on urinary oxalate excretion in calcium stone-forming
More informationCorrelation between Thyroid Function and Bone Mineral Density in Elderly People
IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini
More informationUrinary Calculus Disease. Urinary Stones: Simplified Metabolic Evaluation. Urinary Calculus Disease. Urinary Calculus Disease 2/8/2008
Urinary Stones: Simplified Metabolic Evaluation Marshall L. Stoller, M.D. Professor and Vice Chairman Department of Urology University of California San Francisco Incidence: 7-21/10,000 3 men: 1 woman
More informationNEPHROLITHIASIS Etiology, stone composition, medical management, and prevention
NEPHROLITHIASIS Etiology, stone composition, medical management, and prevention Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Epidemiology Prevalence 2-3%, maybe in
More informationBone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented
More informationCa, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary
Ca, Mg metabolism, bone diseases Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Calcium homeostasis Ca 1000g in adults 99% in bones (extracellular with Mg, P) Plasma/intracellular
More informationMen and Osteoporosis So you think that it can t happen to you
Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School
More informationEffect of BMI and Urinary ph on Urolithiasis and Its Composition
Saudi J Kidney Dis Transpl 2013;24(1):60-66 2013 Saudi Center for Organ Transplantation Original Article Saudi Journal of Kidney Diseases and Transplantation Effect of BMI and Urinary ph on Urolithiasis
More information9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy
The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department
More informationSodium and Potassium Intake and Cardiovascular and Bone Health:
Sodium and Potassium Intake and Cardiovascular and Bone Health: How Important is the Ratio? Connie M. Weaver Nutrition Science Purdue University Disclosures Boards/Scientific Advisory Committees ILSI Showalter
More informationFrequency of renal phosphate leak among patients with calcium nephrolithiasis
Kidney International, Vol. 60 (2001), pp. 272 276 Frequency of renal phosphate leak among patients with calcium nephrolithiasis DOMINIQUE PRIÉ, VINCENT RAVERY, LAURENT BOCCON-GIBOD, and GÉRARD FRIEDLANDER
More informationDEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN
October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.
More informationHypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance
Normal value Hypocalcemia Serum calcium Total mg/dl Ionized mg/dl Cord blood 9.0 ~ 11.5 5.0 ~ 6.o New born (1 st 24 hrs) 9.0 ~ 10.6 4.3 ~ 5.1 24~ 48 hrs 7.0 ~12.0 4.0 ~4.7 Child 8.8 ~10.8 4.8 ~4.92 There
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationOriginal Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism
www.ijcem.com/ijcem807001 Original Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism Itoko Hisa 1, Hiroshi Kaji 1, Yoshifumi
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationApproach to a patient with hypercalcemia
Approach to a patient with hypercalcemia Ana-Maria Chindris, MD Division of Endocrinology Mayo Clinic Florida 2013 MFMER slide-1 Background Hypercalcemia is a problem frequently encountered in clinical
More informationBone and Metabolic Markers in Women With Recurrent Calcium Stones
www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.3.177 Endourology/Urolithiasis Bone and Metabolic Markers in Women With Recurrent Calcium Stones Miguel Angel Arrabal-Polo, Miguel Arrabal-Martin,
More informationAssociation of serum biochemical metabolic panel with stone composition
bs_bs_banner International Journal of Urology (2015) 22, 195 199 doi: 10.1111/iju.12632 Original Article: Clinical Investigation Association of serum biochemical metabolic panel with stone composition
More informationManagement of common uroliths through diet
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Management of common uroliths through diet Author : Marge Chandler Categories : Canine, Companion animal, Feline, Vets Date
More informationBone Densitometry Pathway
Bone Densitometry Pathway The goal of the Bone Densitometry pathway is to manage our diagnosed osteopenic and osteoporotic patients, educate and monitor the patient population at risk for bone density
More informationNew aspects of acid-base disorders
New aspects of acid-base disorders I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Division of Nephrology, Hypertension and Transplantation University of Florida College of Medicine
More informationInborn errors of metabolism presenting with kidney stones: clinical aspects. Francesco Emma
Inborn errors of metabolism presenting with kidney stones: clinical aspects Francesco Emma Division of Nephrology and Dialysis Bambino Gesù Children s Hospital, IRCCS Rome, Italy September 6, 2016 Palazzo
More informationElecsys bone marker panel. Optimal patient management starts in the laboratory
bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic
More informationPrevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis
Urol Res (2012) 40:53 59 DOI 10.1007/s00240-011-0397-3 ORIGINAL PAPER Prevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis
More informationCITRATE IS ATRICARBOXYLIC acid normally
Causes of Hypocitraturia in Recurrent Calcium Stone Formers: Focusing on Urinary Potassium Excretion Somnuek Domrongkitchaiporn, MD, Wasana Stitchantrakul, MSc, and Wachira Kochakarn, MD Background: Multiple
More informationOsteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.
Osteoporosis When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of. Osteoblasts by definition are those cells present in the bone and are involved
More informationEQUILIBRIUM VERSUS SUPERSATURATED URINE HYPOTHESIS IN CALCIUM SALT UROLITHIASIS: A NEW THEORETICAL AND PRACTICAL APPROACH TO A CLINICAL PROBLEM
Scanning Microscopy Vol. 13, No. 2-3, 1999 (Pages 261-265) 0891-7035/99$5.00+.25 Scanning Microscopy International, Chicago Equilibrium (AMF O Hare), model for IL calcium 60666 USA salt urolithiasis EQUILIBRIUM
More informationUrine Stone Screen requirements
Urine Stone Screen requirements Unique Identifying Index Number LP/PA/CB/CBSP030 Version number 4 Issue Date (this version) 03.08.15 Document Type Accreditation or Licensing Standard to which this applies
More informationChapter 5: Evaluation and treatment of kidney transplant bone disease Kidney International (2009) 76 (Suppl 113), S100 S110; doi: /ki.2009.
http://www.kidney-international.org & 2009 KDIGO Chapter 5: Evaluation and treatment of kidney transplant bone disease ; doi:10.1038/ki.2009.193 Grade for strength of recommendation a Strength Wording
More informationEvaluation of different urinary constituent ratios in renal stone formers
Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 2010, 1 (3) : 50-55 (http://scholarsresearchlibrary.com/archive.html) ISSN 0976-1233 CODEN (USA): ABRNBW Evaluation of
More informationDisclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco Disclosure and Conflicts of Interest
More informationEndocrine Regulation of Calcium and Phosphate Metabolism
Endocrine Regulation of Calcium and Phosphate Metabolism Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C516, Block C, Research Building, School of Medicine Tel: 88208252 Email: wanghuiping@zju.edu.cn
More informationThe Nuts and Bolts of Kidney Stones. Soha Zouwail Consultant Chemical Pathology UHW Renal Training Day 2019
The Nuts and Bolts of Kidney Stones Soha Zouwail Consultant Chemical Pathology UHW Renal Training Day 2019 Urinary Calculi Prevalence and incidence of kidney stones increasing across the world Environmental
More informationRenal Data from Asia Africa
Saudi J Kidney Dis Transpl 2013;24(4):838-843 2013 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from Asia Africa Metabolic Evaluation in First-Time
More informationSchedule of taking calcium supplement and the risk of nephrolithiasis
Kidney International, Vol. 65 (2004), pp. 1835 1841 Schedule of taking calcium supplement and the risk of nephrolithiasis SOMNUEK DOMRONGKITCHAIPORN,WICHAI SOPASSATHIT, WASANA STITCHANTRAKUL, SURASING
More informationEffect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats
original article http://www.kidney-international.org & International Society of Nephrology Effect of cinacalcet on urine calcium excretion and in genetic hypercalciuric stone-forming rats DA Bushinsky,
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 21, 2005 Maria Mesquita, 1 Eric Wittersheim, 2 Anne Demulder, 2 Max Dratwa, 1 Pierre Bergmann 3 Bone Cytokines and Renal Osteodystrophy
More informationHyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012
Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco
More informationA case of hereditary hypophosphataemic rickets with hypercalciuria (HHRH)
Case Reports A case of hereditary hypophosphataemic rickets with hypercalciuria (HHRH) M N Lucas 1, Savithri Dias 2 Sri Lanka Journal of Child Health, 2006; 35:141-3 (Key words: hereditary hypophosphataemic
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationMetabolic Stone Work-Up For Stone Prevention. Dr. Hazem Elmansy, MD, MSC, FRCSC Assistant Professor, NOSM, Urology Department
Metabolic Stone Work-Up For Stone Prevention Dr. Hazem Elmansy, MD, MSC, FRCSC Assistant Professor, NOSM, Urology Department Faculty/Presenter Disclosure Slide Faculty: Hazem Elmansy Relationships with
More informationURINARY EXCRETION OF CALCIUM AND CREATININE IN RELATION TO AGE AND BODY WEIGHT IN NORMAL SUBJECTS AND PATIENTS WITH RENAL CALCULUS
Clinical Science (1970) 38,601-612. URINARY EXCRETION OF CALCIUM AND CREATININE IN RELATION TO AGE AND BODY WEIGHT IN NORMAL SUBJECTS AND PATIENTS WITH RENAL CALCULUS L. BULUSU, A. HODGKINSON, B. E. C.
More informationOsteoporosis challenges
Osteoporosis challenges Osteoporosis challenges Who should have a fracture risk assessment? Who to treat? Drugs, holidays and unusual adverse effects Fracture liaison service? The size of the problem 1
More informationBone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationOsteoporosis/Fracture Prevention
Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team
More informationDietary Protein and Bone Health Emphasis: Animal Protein
USDA-ARS Human Nutrition Research Centers Dietary Protein and Bone Health Emphasis: Animal Protein Z.K. (Fariba) Roughead, PhD, RD Research Nutritionist USDA-ARS Grand Forks Human Nutrition Research Center
More informationEfficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:
More information"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy
"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy Rebecca S. Sippel, M.D. Assistant Professor Department of Surgery Section of Endocrine Surgery University of Wisconsin Primary Hyperparathyroidism
More informationOsteoporosis. Overview
v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)
More informationIdentification and qualitative Analysis. of Renal Calculi
Identification and qualitative Analysis of Renal Calculi 1 -Renal Calculi: Kidney stones, renal calculi or renal lithiasis (stone formation) are small, hard deposits that form inside your kidneys. The
More informationThe effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women
European Journal of Clinical Nutrition (1997) 51, 394±399 ß 1997 Stockton Press. All rights reserved 0954±3007/97 $12.00 in premenopausal and postmenopausal women CEL Evans, AY Chughtai, A Blumsohn, M
More informationRelationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic Fracture Patients
J Bone Metab 2015;22:9-15 http://dx.doi.org/10.11005/jbm.2015.22.1.9 pissn 2287-6375 eissn 2287-7029 Original Article Relationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic
More informationRecurrent stone formers-metabolic evaluation: a must investigation
International Surgery Journal Bhangu GS et al. Int Surg J. 2017 Jan;4(1):86-90 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20163972
More informationPRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery
ENDOCRINE DISORDER PRIMARY HYPERPARATHYROIDISM Roseann P. Velez, DNP, FNP Francis J. Velez, MD, FACS Common Complex Insidious Chronic Global Only cure is surgery HYPERPARATHYROIDISM PARATHRYOID GLANDS
More informationRETRACTED ARTICLE. Association between serum vitamin D levels and the risk of kidney stone: evidence from a meta-analysis
Wang et al. Nutrition Journal (2016) 15:32 DOI 10.1186/s12937-016-0148-y RESEARCH Association between serum vitamin D levels and the risk of kidney stone: evidence from a meta-analysis Hai Wang *, Libo
More informationnogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,
More informationStudy of association of serum bicarbonate levels with mortality in chronic kidney disease
International Journal of Research in Medical Sciences Kumar S et al. Int J Res Med Sci. 2016 Nov;4(11):4852-4856 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163779
More informationO. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster
DOI 10.1007/s00296-012-2460-y ORIGINAL ARTICLE Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationThe Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake
Korean J Fam Med. 2013;34:43-48 http://dx.doi.org/10.4082/kjfm.2013.34.1.43 The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake Original Article Junga Kim, Byungsung
More informationEffective Health Care Program
Comparative Effectiveness Review Number 61 Effective Health Care Program Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies Executive Summary Introduction Nephrolithiasis
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationRENAL FUNCTION An Overview
RENAL FUNCTION An Overview UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ. Temple 1 Kidneys
More informationBone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017
Bone Health in Celiac Disease Partha S. Sinha MD, PhD October 29 th, 2017 No Disclosures Objectives Recognize the mechanisms by which celiac disease can affect bone health Review what diagnostic tests
More informationAdditional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr.
Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015 Dr. Tessem Osteoporosis is a public health problem in all stages of life. Many
More informationHyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE
Hyperparathyroidism When to Suspect, How to Diagnose, When and How to Intervene Johanna A. Pallotta, MD, FACP, FACE Potential conflicts of interest: None Johanna A. Pallotta, MD Outline Definition of hyperparathyroidism
More informationchapter 1 & 2009 KDIGO
http://www.kidney-international.org chapter 1 & 2009 DIGO Chapter 1: Introduction and definition of CD MBD and the development of the guideline statements idney International (2009) 76 (Suppl 113), S3
More informationApproximately 80% of kidney stones contain calcium,
Determinants of 24-hour Urinary Oxalate Excretion Eric N. Taylor* and Gary C. Curhan* *Renal Division and Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School,
More informationPOSTMENOPAUSAL BONE LOSS poses a significant
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(6):3528 3533 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-2451 Effects of Potassium Alkali
More informationChanges in urinary risk profile after shortterm low sodium and low calcium diet in recurrent Swiss kidney stone formers
Seeger et al. BMC Nephrology (2017) 18:349 DOI 10.1186/s12882-017-0755-7 RESEARCH ARTICLE Changes in urinary risk profile after shortterm low sodium and low calcium diet in recurrent Swiss kidney stone
More informationUCLA Nutrition Bytes. Title. Permalink. Journal ISSN. Author. Publication Date. Calcium and Hypertension. https://escholarship.org/uc/item/68b658ss
UCLA Nutrition Bytes Title Calcium and Hypertension Permalink https://escholarship.org/uc/item/68b658ss Journal Nutrition Bytes, 4(2) ISSN 1548-601X Author Martinez, Christina Publication Date 1998-01-01
More informationGuideline for the investigation and management of osteoporosis. for hospitals and General Practice
Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density
More informationOsteoporosis. Treatment of a Silently Developing Disease
Osteoporosis Treatment of a Silently Developing Disease Marc K. Drezner, MD Senior Associate Dean Emeritus Professor of Medicine Emeritus University of Wisconsin-Madison Auditorium The Forest at Duke October
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Prevalence and Pattern of Mineral Bone Disorder in Chronic Kidney Disease Patients Using Serum
More informationMetabolic Bone Disease Related to Chronic Kidney Disease
Metabolic Bone Disease Related to Chronic Kidney Disease Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic Bone Center Dept of Medicine, Division of Endocrinology Disclosure DSMB member for denosumab
More informationDisclosure. Topic Outline. Calcium, Vitamin D, PTH Disorders. PTH/Calcium-Normal Physiology. I have nothing to disclose
Disclosure Calcium, Vitamin D, PTH Disorders I have nothing to disclose Chienying Liu MD Associate Clinical Professor Division of Endocrinology & Metabolism UCSF Topic Outline Calcium/Vitamin D/PTH physiology
More information